Maximus (NYSE:MMS) Issues Quarterly Earnings Results, Beats Estimates By $0.26 EPS

Maximus (NYSE:MMS) announced its earnings results on Wednesday. The health services provider reported $1.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.26, Briefing.com reports. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period in the previous year, the business earned $0.80 earnings per share. The firm’s quarterly revenue was up 11.7% compared to the same quarter last year. Maximus updated its FY24 guidance to $5.65-5.85 EPS and its FY 2024 guidance to 5.650-5.850 EPS.

Maximus Trading Down 0.1 %

Maximus stock traded down $0.08 during mid-day trading on Thursday, hitting $84.04. The company’s stock had a trading volume of 453,130 shares, compared to its average volume of 326,124. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. The stock has a market cap of $5.13 billion, a price-to-earnings ratio of 28.75 and a beta of 0.72. The business has a 50 day moving average price of $82.34 and a 200-day moving average price of $81.63. Maximus has a 12 month low of $72.39 and a 12 month high of $90.65.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.43%. The ex-dividend date of this dividend is Tuesday, May 14th. Maximus’s dividend payout ratio is presently 39.74%.

Insiders Place Their Bets

In other Maximus news, CFO David Mutryn sold 8,000 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the sale, the chief financial officer now directly owns 5,124 shares of the company’s stock, valued at $430,159.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.40% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.